Literature DB >> 776436

External detection and visualization of myocardial ischemia with 11C-substrates in vitro and in vivo.

E S Weiss, E J Hoffman, M E Phelps, M J Welch, P D Henry, M M Ter-Pogossian, B E Sobel.   

Abstract

To characterize externally detectable changes in myocardial metabolism of free fatty acids (FFA) and glucose associated with ischemia, isovolumically beating rabbit hearts were perfused under conditions of selected flows with cyclotron-produced, short-lived (t1/2 - 20.4 minutes), 11C-labeled isotopes of glucose and FFA. Tension-time index decreased 83% and lactate production increased from 0.5 +/- 1.9 (SE) to 5.3 +/- 2.1 mumol/min per g of dry weight reflecting myocardial ischemia after flow was reduced from 20 to 5 ml/min. After 30 minutes of low flow the myocardial accumulation of 11C-octanoate, expressed as the extraction fraction, declined from 56 +/- 15% to 30 +/- 3%, reflecting metabolic suppression of FFA extraction during low flow. Effects attributable exclusively to prolonged residence time were excluded. Similar results were obtained with 11C-palmitate. The myocardial avidity for 11C-palmitate was demonstrable by rectilinear whole body scanning in dogs given 5 mCi of the agent intravenously. Diminished 11C-palmitate uptake in zones of myocardium rendered ischemic for 20 minutes prior to reflow in intact dogs was delineated by electrocardiographically gated positron-emission transaxial computer reconstruction tomography. Thus, diminished 11C-FFA extraction, externally detectable, accompanies decreased perfusion in isolated perfused hearts, and decreased 11C-FFA uptake reflecting myocardial ischemia in vivo can be evaluated noninvasively by positron-emission transaxial tomography.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 776436     DOI: 10.1161/01.res.39.1.24

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  27 in total

Review 1.  Future aspects of BMIPP.

Authors:  N Tamaki; K Morita; E Tsukamoto; Y Kawai
Journal:  Int J Card Imaging       Date:  1999-02

2.  Metabolic reserve in normal myocardium assessed by positron emission tomography with C-11 palmitate.

Authors:  N Tamaki; M Kawamoto; N Takahashi; Y Yonekura; Y Magata; R Nohara; H Kambara; C Kawai; J Konishi
Journal:  Ann Nucl Med       Date:  1991-07       Impact factor: 2.668

3.  The right stuff.

Authors:  H W Strauss
Journal:  J Nucl Cardiol       Date:  1995 Jan-Feb       Impact factor: 5.952

4.  Regional rates of myocardial fatty acid metabolism: comparison with coronary angiography and ventriculography.

Authors:  N Schad; R K Wagner; J Hallermeier; H J Daus; A Vattimo; P Bertelli
Journal:  Eur J Nucl Med       Date:  1990

Review 5.  Imaging of myocardial fatty acid oxidation.

Authors:  Kieren J Mather; Timothy R DeGrado
Journal:  Biochim Biophys Acta       Date:  2016-02-27

6.  Mathematical model of the metabolism of 123I-16-iodo-9-hexadecenoic acid in an isolated rat heart. Validation by comparison with experimental measurements.

Authors:  F Dubois; J C Depresseux; L Bontemps; L Demaison; C Keriel; J P Mathieu; C Pernin; D Marti-Batlle; M Vidal; P Cuchet
Journal:  Eur J Nucl Med       Date:  1986

Review 7.  Positron emission tomography.

Authors:  Y L Yamamoto; C J Thompson; M Diksic; E Meyer; W H Feindel
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

8.  The elimination rate of 123I-heptadecanoic acid after intracoronary and intravenous administration.

Authors:  F C Visser; M J van Eenige; E E van der Wall; G Westera; C J van Engelen; A van Lingen; C C de Cock; W den Hollander; G A Heidendal; J P Roos
Journal:  Eur J Nucl Med       Date:  1985

9.  Tellurium-labeled fatty-acid analogs: relationship of heteroatom position to myocardial kinetics.

Authors:  R D Okada; F F Knapp; M M Goodman; D Elmaleh; H W Strauss
Journal:  Eur J Nucl Med       Date:  1985

10.  Dynamic myocardial scintigraphy with 123I-labeled free fatty acids in patients with myocardial infarction.

Authors:  E E van der Wall; W den Hollander; G A Heidendal; G Westera; P A Majid; J P Roos
Journal:  Eur J Nucl Med       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.